Patients with Alzheimer's disease use metamemory to attenuate the Jacoby-Whitehouse illusion

被引:16
作者
Willems, Sylvie [1 ]
Germain, Sophie [1 ]
Salmon, Eric [1 ,2 ]
Van der Linden, Martial [1 ,3 ]
机构
[1] Univ Liege, B-4000 Liege, Belgium
[2] CHU Liege, Memory Ctr, Liege, Belgium
[3] Univ Geneva, CH-1211 Geneva 4, Switzerland
关键词
False recognition; Alzheimer's disease; Perceptual fluency; Metamemory; CONCEPTUAL FLUENCY; FALSE RECOGNITION; PERCEPTUAL FLUENCY; WORD-FREQUENCY; MEMORY; ATTRIBUTION; JUDGMENTS; DEMENTIA; PICTURES;
D O I
10.1016/j.neuropsychologia.2009.04.029
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Patients with Alzheimer's disease (AD) relying predominantly on familiarity for recognition, research has suggested that they may be particularly susceptible to memory illusions driven by conceptual fluency. Using the Jacoby and Whitehouse [Jacoby, L.L., & Whitehouse, K. (1989). An illusion of memory: False recognition influenced by unconscious perception. Journal of Experimental Psychology: General, 118, 126-135] illusion paradigm, we extended these findings and found that AD patients were also sensitive to perceptually driven false recognition. However, AD patients were equally able to disregard perceptual fluency when there was a shift in the sensory modality of the study and test stages. Overall, these findings support the notion that patients with AD can be susceptible to fluency-based memory illusions but these patients can strategically control the fluency attribution following their metamemory expectation in exactly the same way as elderly adults and young adults. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2672 / 2676
页数:5
相关论文
共 50 条
  • [31] Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice
    Koric, L.
    Felician, O.
    Ceccaldi, M.
    REVUE NEUROLOGIQUE, 2011, 167 (6-7) : 474 - 484
  • [32] Factors influencing confabulation in Japanese patients with Alzheimer's disease
    Okamoto, Toyoko
    Yamamoto, Yasuji
    Sakai, Kazuo
    Matsuyama, Kenichi
    Hashimoto, Takeshi
    Hayashi, Atsuko
    PSYCHOGERIATRICS, 2018, 18 (04) : 276 - 282
  • [33] Microlinguistic aspects of the oral narrative in patients with Alzheimer's disease
    de Lira, Juliana Onofre
    Ortiz, Karin Zazo
    Campanha, Aline Carvalho
    Ferreira Bertolucci, Paulo Henrique
    Cianciarullo Minett, Thais Soares
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (03) : 404 - 412
  • [34] Early Assessment for Alzheimer's Disease and Dementia Comparison of Two Metamemory Diagnostic Tests
    Perfecto, Kristian
    Ahern, Nancy R.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2013, 51 (09) : 17 - 21
  • [35] The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
    Hansson, Oskar
    Edelmayer, Rebecca M.
    Boxer, Adam L.
    Carrillo, Maria C.
    Mielke, Michelle M.
    Rabinovici, Gil D.
    Salloway, Stephen
    Sperling, Reisa
    Zetterberg, Henrik
    Teunissen, Charlotte E.
    ALZHEIMERS & DEMENTIA, 2022, 18 (12) : 2669 - 2686
  • [36] The use of fiber tractography for identifying patients with Alzheimer’s disease
    Kyung-Rae Dong
    Eun-Hoe Goo
    Jae-Seung Lee
    Woon-Kwan Chung
    Yong-Soon Park
    Journal of the Korean Physical Society, 2013, 62 : 165 - 171
  • [37] Multitarget therapeutic approaches for Alzheimer's and Parkinson's disease: an opportunity or an illusion?
    Matos, Maria Joao
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (15) : 1301 - 1309
  • [38] Use of the Higuchi's fractal dimension for the analysis of MEG recordings from Alzheimer's disease patients
    Gomez, Carlos
    Mediavilla, Angela
    Hornero, Roberto
    Abasolo, Daniel
    Fernandez, Alberto
    MEDICAL ENGINEERING & PHYSICS, 2009, 31 (03) : 306 - 313
  • [39] Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease
    Madhu, Leelavathi N.
    Somayaji, Yogish
    Shetty, Ashok K.
    AGEING RESEARCH REVIEWS, 2022, 78
  • [40] β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
    Daniel C. Shippy
    Connor Wilhelm
    Patel A. Viharkumar
    Thomas J. Raife
    Tyler K. Ulland
    Journal of Neuroinflammation, 17